Aims and scope
Tobacco Induced Diseases encompasses all aspects of tobacco induced diseases and their prevention. The journal aims to further the development of the scientific basis for the biological effects of tobacco smoke and its active components and to describe the distribution of tobacco diseases throughout the world.
The journal encourages the submission of articles from all medical, biological and psychosocial disciplines, ranging from medical and dental clinicians, through nurses and health professionals to basic biomedical scientists.
Tobacco Induced Diseases is the official journal of the International Society for the Prevention of Tobacco Induced Diseases.
Presubmission enquiries about the suitability of your manuscript are welcomed; please email the editorial office who will respond to your enquiry as soon as possible.
Research, commentaries and reviews funded directly or indirectly by the tobacco industry or by any of its subsidiary industries, societies, agencies or individuals associated with the industry are ineligible to be considered for publication in Tobacco Induced Diseases.
Open access publishing is not without costs. Tobacco Induced Diseases therefore levies an article-processing charge of £1370/$2145/€1745 for each article accepted for publication. If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
BioMed Central provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
All articles published by Tobacco Induced Diseases are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Tobacco Induced Diseases you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
All articles published in Tobacco Induced Diseases are included in:
- PubMed Central
- Science Citation Index Expanded
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
Tobacco Induced Diseases has an Impact Factor of 1.938.
Tobacco Induced Diseases operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
All manuscripts submitted to Tobacco Induced Diseases should adhere to BioMed Central's editorial policies.
Citing articles in Tobacco Induced Diseases
Articles in Tobacco Induced Diseases should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Tob Induced Dis [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Tob Induced Dis 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.
Why publish your article in Tobacco Induced Diseases
Tobacco Induced Diseases's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Tobacco Induced Diseases offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in Tobacco Induced Diseases gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Tobacco Induced Diseases are included in article alerts and regular email updates. Some may be highlighted on Tobacco Induced Diseases’s pages and on the BioMed Central homepage.
In addition, articles published in Tobacco Induced Diseases may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Tobacco Induced Diseases. A list of articles recently press-released by journals published by BioMed Central is available here.
As an author of an article published in Tobacco Induced Diseases you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.